Groenhuysen Wilhelmus CM's Form 4 filing
NovoCure Ltd (NVCR) · filed Feb 29, 2024
- Accession no.
- 0001562180-24-001980
- Filed
- Feb 29, 2024
- Trade date
- Dec 31, 2023-Feb 28, 2024
- Filing delay
- 60 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $37.2K. It was filed 60 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Groenhuysen Wilhelmus CMCIK 0001264783 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | Ordinary Shares | AGrant or awardAcquired | +3 | $12.69F2 | +$38.07 | 209,828 | Direct | |
| Feb 27, 2024 | Ordinary Shares | AGrant or awardAcquired | +47,034 | $16.30 | +$766,654.2 | 256,862 | Direct | |
| Feb 28, 2024 | Ordinary Shares | SSaleDisposed | −2,303 | $16.14 | −$37,170.42 | 254,559 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Ordinary Shares | AGrant or awardAcquired | +71,920 | $16.30 | +$1,172,296 | 71,920 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2023.
Referenced by the price of 1 transaction in Table I.